A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma

Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients and methods...

Full description

Saved in:
Bibliographic Details
Published inRadiotherapy and oncology Vol. 84; no. 1; pp. 18 - 22
Main Authors O’Rourke, Noelle, Garcia, Jose Curto, Paul, Jim, Lawless, Claire, McMenemin, Rhona, Hill, Jennifer
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.07.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients and methods Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21 Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected. Results Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms ( p = 0.748). Conclusions Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies.
AbstractList To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21 Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected. Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms ( p = 0.748). Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies.
To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected. Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms (p=0.748). Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies.
Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients and methods Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21 Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected. Results Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms ( p = 0.748). Conclusions Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies.
Author McMenemin, Rhona
Garcia, Jose Curto
Hill, Jennifer
O’Rourke, Noelle
Paul, Jim
Lawless, Claire
Author_xml – sequence: 1
  fullname: O’Rourke, Noelle
– sequence: 2
  fullname: Garcia, Jose Curto
– sequence: 3
  fullname: Paul, Jim
– sequence: 4
  fullname: Lawless, Claire
– sequence: 5
  fullname: McMenemin, Rhona
– sequence: 6
  fullname: Hill, Jennifer
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17588698$$D View this record in MEDLINE/PubMed
BookMark eNqFkV1LHTEQhkOx6NH6D0rZP7DrZL8SbwQRbQXBC-11yMekzWk2OSQ5wvn3zXKEQm-8SiDvM5l55pychBiQkK8UOgp0vtp2SZoYdNcDsA6mDvr-E9lQzq5b4JydkE2NsZbTEc7Iec5bAOhhYKfkjLKJ8_mab4i8bZIMJi4uo2l0DCVF7-u1JCd9E23jQsH0hqG4GJrsClbAuFh-Y5K7Q31uFundryBDaXYe96liC-Y14F1c5Bfy2Uqf8fL9vCA_H-5f7360T8_fH-9un1o90qm0I7WKq3HQHHDWI5-wr93PCkCNM7VsttYaOQ4TMFAalGKTVMpaPVCjh8EMF2Q81tUp5pzQil1yi0wHQUGsxsRWHI2J1ZiASVRjFft2xHZ7taD5B70rqoGbYwBr828Ok8jaYdBoXEJdhInuox_-L6C9C05L_wcPmLdxn0IVI6jIvQDxsm5tXVodFPo68PAXEVKYBA
CitedBy_id crossref_primary_10_1093_annonc_mdq471
crossref_primary_10_1007_s11864_023_01148_2
crossref_primary_10_1016_j_critrevonc_2016_05_004
crossref_primary_10_1007_s13665_012_0009_x
crossref_primary_10_1200_JCO_18_01678
crossref_primary_10_1016_j_clon_2010_01_009
crossref_primary_10_1586_era_10_169
crossref_primary_10_1510_icvts_2010_256214
crossref_primary_10_1093_ejcts_ezaa158
crossref_primary_10_1111_j_1445_5994_2010_02223_x
crossref_primary_10_1097_COC_0b013e3181d31f02
crossref_primary_10_12968_hmed_2015_76_7_384
crossref_primary_10_1007_s10269_016_2642_4
crossref_primary_10_1093_annonc_mdp134
crossref_primary_10_1097_JTO_0b013e3181f1cf2b
crossref_primary_10_1016_S1877_1203_09_72519_4
crossref_primary_10_1016_j_lungcan_2018_07_007
crossref_primary_10_1111_j_1445_5994_2012_02925_x
crossref_primary_10_1016_S1877_1203_10_70023_9
crossref_primary_10_1111_crj_12938
crossref_primary_10_1016_j_lungcan_2009_06_014
crossref_primary_10_1016_j_radonc_2017_08_003
crossref_primary_10_1016_j_rpor_2012_07_015
crossref_primary_10_1093_annonc_mdq173
crossref_primary_10_1111_j_1743_7563_2010_01319_x
crossref_primary_10_1136_thoraxjnl_2017_211321
crossref_primary_10_1007_s15004_022_9127_y
crossref_primary_10_1016_S0761_8425_08_82026_8
crossref_primary_10_1016_j_lungcan_2015_03_013
crossref_primary_10_26442_18151434_2020_4_200255
crossref_primary_10_1097_CCO_0b013e328324bc30
crossref_primary_10_1016_j_ejca_2011_05_012
crossref_primary_10_1016_j_jtcvs_2013_07_012
crossref_primary_10_1111_j_1759_7714_2010_00001_x
crossref_primary_10_18093_0869_0189_2018_28_5_531_557
crossref_primary_10_5306_wjco_v12_i8_581
crossref_primary_10_1093_annonc_mdv199
crossref_primary_10_1007_s13665_013_0044_2
crossref_primary_10_1016_j_ctrv_2021_102265
crossref_primary_10_1016_S1470_2045_16_30387_4
crossref_primary_10_1183_13993003_00953_2019
crossref_primary_10_1097_MCP_0b013e3282fcea50
crossref_primary_10_1186_1750_1172_3_34
crossref_primary_10_1097_LBR_0000000000000100
crossref_primary_10_1016_j_lungcan_2007_12_022
crossref_primary_10_1016_j_ijrobp_2009_06_037
crossref_primary_10_1016_j_lungcan_2019_03_023
crossref_primary_10_1634_theoncologist_2010_0185
crossref_primary_10_1007_s00270_017_1583_7
crossref_primary_10_1002_14651858_CD012541
crossref_primary_10_1136_bmjopen_2015_010589
crossref_primary_10_1097_MCP_0b013e3282fe9a04
crossref_primary_10_2217_lmt_15_27
crossref_primary_10_1007_s11864_020_00807_y
crossref_primary_10_1097_CPM_0b013e318235181f
crossref_primary_10_1016_j_ctro_2018_09_004
crossref_primary_10_1080_17476348_2019_1627203
crossref_primary_10_1371_journal_pone_0190257
crossref_primary_10_1016_S1877_1203_19_30101_6
crossref_primary_10_1016_j_lungcan_2014_01_021
crossref_primary_10_1007_s00520_013_1753_3
crossref_primary_10_1016_S1877_1203_20_30095_1
crossref_primary_10_1111_1759_7714_12008
crossref_primary_10_1016_S1470_2045_16_30132_2
crossref_primary_10_1016_S1877_1203_22_00126_4
crossref_primary_10_1016_j_radonc_2011_08_038
crossref_primary_10_1200_JCO_2017_76_6394
crossref_primary_10_1378_chest_13_3057
crossref_primary_10_1136_bmjopen_2016_013324
crossref_primary_10_1016_j_canrad_2017_06_011
crossref_primary_10_1016_S1877_1203_18_30030_2
crossref_primary_10_2217_fon_09_7
crossref_primary_10_1016_j_ccm_2021_08_004
crossref_primary_10_1510_icvts_2011_267252
crossref_primary_10_1684_bdc_2013_1857
crossref_primary_10_3816_CLC_2009_n_005
crossref_primary_10_1378_chest_14_0872
crossref_primary_10_1016_j_rmr_2016_10_005
crossref_primary_10_18093_0869_0189_2010_3_11_29
crossref_primary_10_1517_14728210903074563
crossref_primary_10_1016_S1470_2045_16_30095_X
crossref_primary_10_1053_j_ro_2013_03_017
crossref_primary_10_1016_j_jtho_2018_06_011
crossref_primary_10_1088_0031_9155_53_13_013
crossref_primary_10_1159_000494500
crossref_primary_10_1097_MCP_0000000000000385
crossref_primary_10_18093_0869_0189_2018_28_6_655_679
crossref_primary_10_1016_j_brachy_2009_08_009
crossref_primary_10_1111_j_1440_1843_2011_01948_x
crossref_primary_10_1111_php_13065
crossref_primary_10_1200_JCO_2008_19_8523
crossref_primary_10_1183_16000617_0063_2016
crossref_primary_10_1016_j_critrevonc_2021_103278
crossref_primary_10_1136_bmjopen_2014_006673
crossref_primary_10_1016_j_pneumo_2012_12_003
crossref_primary_10_1016_S1877_1203_23_00151_9
crossref_primary_10_1016_j_ctrv_2012_11_004
crossref_primary_10_1186_s12885_015_1881_x
crossref_primary_10_1016_S1470_2045_17_30459_X
crossref_primary_10_1016_S1877_1203_21_00111_7
crossref_primary_10_1080_02841860701754182
crossref_primary_10_1186_s12890_016_0318_x
crossref_primary_10_1016_j_critrevonc_2010_04_004
Cites_doi 10.1016/S0936-6555(05)80540-0
10.1378/chest.108.3.754
10.1016/S0167-8140(03)00229-9
10.1038/sj.bjc.6601957
ContentType Journal Article
Copyright Elsevier Ireland Ltd
2007 Elsevier Ireland Ltd
Copyright_xml – notice: Elsevier Ireland Ltd
– notice: 2007 Elsevier Ireland Ltd
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1016/j.radonc.2007.05.022
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-0887
EndPage 22
ExternalDocumentID 10_1016_j_radonc_2007_05_022
17588698
S0167814007002435
1_s2_0_S0167814007002435
Genre Clinical Trial, Phase III
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
0SF
123
1B1
1P~
1RT
1~.
1~5
29P
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABMAC
ABMZM
ABOCM
ABUDA
ABXDB
ACDAQ
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADVLN
AEBSH
AEHWI
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
E3Z
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HED
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
KOM
M27
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UV1
WUQ
X7M
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ID FETCH-LOGICAL-c415t-41fb8b43c80e6c485e21676b00b461f76fffda435070bc0bb75abbffc31dc33d3
IEDL.DBID .~1
ISSN 0167-8140
IngestDate Thu Sep 26 17:36:56 EDT 2024
Sat Sep 28 07:46:46 EDT 2024
Fri Feb 23 02:32:46 EST 2024
Tue Oct 15 22:54:33 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Prophylactic radiotherapy
Mesothelioma
Drain site
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c415t-41fb8b43c80e6c485e21676b00b461f76fffda435070bc0bb75abbffc31dc33d3
PMID 17588698
PageCount 5
ParticipantIDs crossref_primary_10_1016_j_radonc_2007_05_022
pubmed_primary_17588698
elsevier_sciencedirect_doi_10_1016_j_radonc_2007_05_022
elsevier_clinicalkeyesjournals_1_s2_0_S0167814007002435
PublicationCentury 2000
PublicationDate 2007-07-01
PublicationDateYYYYMMDD 2007-07-01
PublicationDate_xml – month: 07
  year: 2007
  text: 2007-07-01
  day: 01
PublicationDecade 2000
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Radiotherapy and oncology
PublicationTitleAlternate Radiother Oncol
PublicationYear 2007
Publisher Elsevier Ireland Ltd
Publisher_xml – name: Elsevier Ireland Ltd
References Low, Khoury, Matthews (bib1) 1995; 7
De Ruysscher, Stotman (bib3) 2003; 68
Boutin, Rey, Viallat (bib2) 1995; 108
Bydder, Phillips, Joseph (bib4) 2004; 91
17978160 - Eur Respir J. 2007 Nov;30(5):1021
Bydder (10.1016/j.radonc.2007.05.022_bib4) 2004; 91
Boutin (10.1016/j.radonc.2007.05.022_bib2) 1995; 108
Low (10.1016/j.radonc.2007.05.022_bib1) 1995; 7
De Ruysscher (10.1016/j.radonc.2007.05.022_bib3) 2003; 68
References_xml – volume: 68
  start-page: 299
  year: 2003
  end-page: 302
  ident: bib3
  article-title: Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey
  publication-title: Radiother Oncol
  contributor:
    fullname: Stotman
– volume: 108
  start-page: 754
  year: 1995
  end-page: 758
  ident: bib2
  article-title: Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma
  publication-title: Chest
  contributor:
    fullname: Viallat
– volume: 91
  start-page: 9
  year: 2004
  end-page: 10
  ident: bib4
  article-title: A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma
  publication-title: Br J Cancer
  contributor:
    fullname: Joseph
– volume: 7
  start-page: 317
  year: 1995
  end-page: 318
  ident: bib1
  article-title: Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy
  publication-title: Clin Oncol
  contributor:
    fullname: Matthews
– volume: 7
  start-page: 317
  year: 1995
  ident: 10.1016/j.radonc.2007.05.022_bib1
  article-title: Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy
  publication-title: Clin Oncol
  doi: 10.1016/S0936-6555(05)80540-0
  contributor:
    fullname: Low
– volume: 108
  start-page: 754
  year: 1995
  ident: 10.1016/j.radonc.2007.05.022_bib2
  article-title: Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma
  publication-title: Chest
  doi: 10.1378/chest.108.3.754
  contributor:
    fullname: Boutin
– volume: 68
  start-page: 299
  year: 2003
  ident: 10.1016/j.radonc.2007.05.022_bib3
  article-title: Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey
  publication-title: Radiother Oncol
  doi: 10.1016/S0167-8140(03)00229-9
  contributor:
    fullname: De Ruysscher
– volume: 91
  start-page: 9
  year: 2004
  ident: 10.1016/j.radonc.2007.05.022_bib4
  article-title: A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6601957
  contributor:
    fullname: Bydder
SSID ssj0002037
Score 2.3170178
Snippet Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with...
To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to...
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 18
SubjectTerms Aged
Biopsy, Needle - adverse effects
Catheterization - adverse effects
Dose Fractionation
Drain site
Female
Hematology, Oncology and Palliative Medicine
Humans
Male
Mesothelioma
Mesothelioma - pathology
Mesothelioma - radiotherapy
Middle Aged
Neoplasm Seeding
Pleura - pathology
Pleural Neoplasms - pathology
Pleural Neoplasms - radiotherapy
Prophylactic radiotherapy
Surveys and Questionnaires
Title A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0167814007002435
https://dx.doi.org/10.1016/j.radonc.2007.05.022
https://www.ncbi.nlm.nih.gov/pubmed/17588698
Volume 84
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS8MwGA4yQbyI386PkYPXuqRN03ocwzE_EXWwW2i-pLK1Y5sHL_5237QpTjwInhrapA1PkvdNmud9gtC5NjLlXPIgIxELmLWQMioOGA254opqqyq2xQMfjtjNOB6voX4TC-Nold721za9stb-Ttej2Z3leffZEeidXhN0Wier5wLNGbg_6NMXn980j5DUuplO39vlbsLnKo7XPNNl0QgZxhckDP9wTyu-Z7CNtvykEffqeu2gNVPsoo17vy2-h7IeBpejS2gzo7Fnn08gWZ3JgUuL8xVqI3YbxlBA5z766gMe4ylMyF8dKwbPJsZpceCpWbgMk7ycZvtoNLh66Q8Df3ZCoMAlLwFrK1PJIpUSwxVLYxMCAhwGmWSc2oRba3UGqAF6UhEpkziT0loVUa2iSEcHqFWUhTlCODGw6gGAs5AY5vTuTCgJtZSqyEiZ0TYKGsjErJbIEA137E3UELvTLhNBYgEQt1HS4Cqa8E8wWGbhR89CULEIBRG_Wni15I9OIsD-__HNw7oBv2sIC6WUX6bH_37nCdpsfvQSeopay_m7OYMZylJ2qi7YQeu9_tPdo7te3w4fvgCYMuh7
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZKkYAF8X6DB9ZQO3GcMFYVqEDLApW6WfELBbVNRcvAwm_nnDhqEUMltiixE-vz-c6Ov_uM0LU2MuVc8iAjEQuYtXBlVBwwGnLFFdVWlWyLZ94dsMdhPGygTp0L42iV3vdXPr301v5Oy6PZmuZ568UR6J1eExitk9WL19A6c_NjMOqb7wXPIySVcKYT-HbF6_y5kuT1keliUisZxjckDFfEp6Xgc7-Dtv2sEberhu2ihpnsoY2-3xffR1kbQ8zRBXSa0djTz0dwWR7KgQuL8yVuI3Y7xlBB5z796gse4zHMyN8cLQZPR8aJceCxmbkCo7wYZwdocH_32ukG_vCEQEFMngPYVqaSRSolhiuWxiYEBDiMMsk4tQm31uoMYAP4pCJSJnEmpbUqolpFkY4OUXNSTMwxwomBZQ8gnIXEMCd4Z0JJqKVURUbKjJ6goIZMTCuNDFGTx95FBbE77jIRJBYA8QlKalxFnf8JHsvM_PCZCSpmoSDiTxcv1_xlJQICwIpvHlUduGghrJRSfpue_vudV2iz-9rvid7D89MZ2qr_-hJ6jprzj09zAdOVubwszfEHzo3ofw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+randomised+controlled+trial+of+intervention+site+radiotherapy+in+malignant+pleural+mesothelioma&rft.jtitle=Radiotherapy+and+oncology&rft.au=O%E2%80%99Rourke%2C+Noelle&rft.au=Garcia%2C+Jose+Curto&rft.au=Paul%2C+Jim&rft.au=Lawless%2C+Claire&rft.date=2007-07-01&rft.pub=Elsevier+Ireland+Ltd&rft.issn=0167-8140&rft.eissn=1879-0887&rft.volume=84&rft.issue=1&rft.spage=18&rft.epage=22&rft_id=info:doi/10.1016%2Fj.radonc.2007.05.022&rft.externalDocID=S0167814007002435
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01678140%2FS0167814007X80290%2Fcov150h.gif